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exeCutive SummArY
In many countries in sub-Saharan Africa, HIV programs are organized around pediatric or adult care, 
with adolescents who are living with HIV being treated through pediatric care facilities. This has 
important implications for retention of adolescents in HIV care programs especially as they transition 
from pediatric to adult care. Although Uganda is considered a success story in HIV/AIDS programming, 
the extent to which adolescents living with HIV have been retained in care is not well understood. 
Retention in care is important for positive clinical outcomes such as viral load suppression and survival. 
The AIDS Support Organization (TASO) and the Population Council undertook a study to generate 
evidence on the level of and the factors associated with retention of adolescents aged 10–19 years in 
HIV and AIDS programs in Uganda. The study was conducted under the U.S. Agency for International 
Development’s (USAID) HIVCore project led by the Population Council. The study specifically 
examined: (1) the contextual factors that might facilitate or influence retention of adolescents in HIV 
care, treatment, and support services in Uganda; (2) the cascade of HIV care, treatment, and support 
services among adolescents aged 10–19 years in Uganda and how these patterns compare with those of 
adults aged 20 years and above; (3) the level of and trends in retention in care, treatment, and support 
programs among adolescents aged 10–19 years in the country in the context of current HIV and AIDS 
programs at 6, 12, 24, 36, and 48 months following initiation of antiretroviral therapy (ART); and (4) the 
sociodemographic characteristics that are associated with retention in HIV care, treatment, and support 
programs among adolescents in Uganda at three different follow-up periods (12, 24, and 36 months).
The study reviewed existing national policy and program documents on HIV testing, counseling, 
treatment, and support as well as retrospective secondary cohort clinical data from clinics operated by 
TASO in Uganda. TASO implements several HIV-related activities including prevention, counseling, 
testing, treatment, care, and support services as well as capacity development, research, and advocacy. The 
study population for the clinical component comprised: (1) 22,089 adolescents aged 10–19 years and 
33,139 adults aged 20 years and above who received HIV services under the home-based HIV testing 
and counseling (HBHTC) program from 2005 (when TASO initiated the program) to 2011; and (2) 
clinical records of 617 adolescent clients aged 10–19 years (at the time of enrollment) who received 
HIV care, treatment, and support services from TASO clinics between 2006 and 2011. The review of 
policy and program documents as well as the extraction and merging of clinical datasets took place 
from 4–15 November 2013. The HBHTC and ART datasets were obtained from 11 TASO centers. 
The ART datasets were extracted from the following records: Pre-ART Registry, Case Evaluation, ART 
Commencement, Deaths, Monitoring Refills, and Laboratory. We identified a patient cohort within 
the TASO Management Information System who initiated ART since 2006. Analysis involved both 
descriptive statistics and multivariate Cox regression analysis. Descriptive analysis entailed reviewing the 
cascade of HIV care, treatment, and support services under the HBHTC program as well as estimating 
the level of retention in TASO ART programs at 6, 12, 24, 36, and 48 months. Multivariate Cox 
regression analysis was conducted to determine the sociodemographic and clinical factors associated with 
program attrition at 12, 24, and 36 months.
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KeY finDingS
 y The HBHTC program contributed to increasing proportions of adolescents aged 10–19 years being 
enrolled in TASO care centers during the first four years of its operation. In particular, among the 
adolescents who tested HIV positive in TASO’s HBHTC programs, the proportion that was enrolled 
in TASO centers more than quadrupled from 9 percent in 2005 to 41 percent in 2008. However, that 
proportion declined thereafter by about half to 20 percent by 2010.
 y The overall level of retention of adolescents in TASO ART programs was 96 percent at 6 months, 
90 percent at 12 months, 83 percent at 24 months, 76 percent at 36 months, and 71 percent at 48 
months, which is comparable with those of adults in existing studies. However, there were variations in 
the level of retention of various cohorts of adolescents especially from 12 months onwards. Specifically, 
retention at each time period decreased among adolescents initiating ART in each successive year 
after 2006 and the gaps widened with longer duration of observation. The high levels of retention of 
adolescents in TASO treatment programs could, however, be due to the intensive resources geared 
towards targeting whole families with HIV testing, counseling, treatment, and support services. Thus, 
although resources for targeting whole families may not always be available, the programs provide 
valuable lessons for improving access to treatment services for HIV-positive adolescents.
 y The risk of non-retention of adolescents in TASO programs was significantly greater among those who 
obtained their antiretroviral (ARV) drug refills from a health facility than among those who obtained 
the refills from community drug distribution points at all the time points considered (12, 24, and 36 
months). In addition, the risk of non-retention in care was significantly greater among adolescents at 
WHO clinical stage 3 and 4 than among those at stage 1 and 2 at 12 months. The findings suggest that 
community-based ART distribution initiatives and early diagnosis of HIV infection do improve the 
chances of retaining adolescents in ART programs. Variations in the risk of non-retention in treatment 
programs by venue of drug refills could be due to most adolescents receiving drugs from community 
drug distribution points being those with high levels of adherence. A cross-tabulation of adherence 
level and venue of drug refill though, showed that there was no significant association between the two 
attributes, suggesting that counseling and close monitoring might have improved adherence among 
clients who received drug refills from facilities.
 y The risk of non-retention in care was significantly greater among older (15–19 years) than among 
younger (10–14 years) adolescents at 12 and 24 months. In addition, at 24 and 36 months, the risk of 
non-retention in care was significantly greater among adolescents with higher than among those with 
lower CD4 count at the time of initiating ART.
 y Contrary to existing literature (Braitstein et al. 2008) which indicates that females are better at seeking 
healthcare than males, the results of this study showed that with longer duration of observation (at 24 
and 36 months), the risk of non-retention in care was significantly lower among male compared to 
female adolescents.
reCommenDAtionS
 y HIV care, treatment, and support programs in Uganda should strengthen such strategies as community 
drug distribution points, which have the potential to improve retention of adolescents in care and 
treatment, to specifically target those who are at high risk of dropping out.
 y Further research is needed to determine whether setting up transition units to cater to older adolescents 
who receive services from health facilities but are not comfortable with obtaining services from 
pediatric or adult clinics could improve retention among adolescents.
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 y Further research involving collection of primary quantitative and qualitative data is needed to 
determine why later cohorts of adolescents had lower levels of retention in care compared to earlier 
cohorts and why male adolescents had significantly lower risk of non-retention in care compared to 
their female counterparts. 
4   ■   retention of Adolescents Living with hIv in Care, Treatment, and Support programs in Uganda
introDuCtion
Globally, the number of children aged under 15 years who were living with HIV increased from 2.0 
million in 2001 to 2.5 million by the end of 2010 (UNAIDS 2010a). Most of these children (90 
percent) were in sub-Saharan Africa, where the number increased from 1.8 million to 2.3 million 
over the same period (UNAIDS 2010a). New infections and the expansion of antiretroviral treatment 
(ART) contributed to the increased number of children living with HIV (UNAIDS 2011). In Uganda, 
for instance, it was estimated that 190,000 children aged under 15 years were living with HIV as of 
2011, while 21,000 new infections occurred among this age group in that year (UNAIDS 2012). The 
implication is that increasing numbers of children infected with HIV in sub-Saharan Africa mature into 
adolescence and adulthood. As with most adolescents, many of these young people become sexually active 
and even have children (Birungi et al. 2008, 2011). Moreover, many adolescents who were not born with 
HIV become sexually active and expose themselves to the risk of HIV infection by not or inconsistently 
using preventive methods (Hindin and Fatusi 2009). In Uganda, for example, estimates show that HIV 
prevalence among adolescents aged 15–19 years is 2.4 percent (3.0 percent and 1.7 percent among 
adolescent girls and boys respectively) (Ministry of Health et al. 2012). 
Yet, in many countries in sub-Saharan Africa, HIV programs are organized around pediatric or adult care 
with adolescents who are living with HIV being treated through pediatric care facilities. Such facilities are 
ill-equipped to provide adolescents with the information they need to deal with sexual and reproductive 
health (SRH) issues of concern to them. For example, available evidence from Kenya and Uganda shows 
that the majority of adolescents who are living with HIV are very worried about becoming pregnant or 
impregnating someone, disclosing their HIV status, and infecting others and re-infecting themselves; yet 
their preventive practices are just as poor as among adolescents in general (Birungi et al. 2008, 2011). 
Moreover, existing counseling services for adolescents have not provided pragmatic solutions for those 
who are sexually active beyond emphasizing that they should refrain from sexual activity, which in most 
cases is not heeded (Birungi et al. 2008). Evidence from Uganda further shows that many adolescent girls 
disappear from HIV and AIDS programs once they become pregnant and it is obvious that they did not 
heed the counselors’ advice to refrain from sexual activity (Birungi et al. 2009).
The gaps in HIV and AIDS programming for adolescents living with HIV have important implications 
for retention of this age group in HIV care, treatment, and support programs as well as for adherence to 
treatment, especially as they transition from pediatric to adult clinics. For example, available evidence 
indicates that in low-resource settings, adherence to treatment is generally poorer among adolescents 
compared to children or adults (Foster and Fidler 2010). Moreover, although Uganda has been considered 
a success story in HIV and AIDS programming that contributed to substantial declines in HIV prevalence 
over time (Ministry of Health et al. 2012), there has been little consideration of the extent to which the 
country has succeeded in retaining HIV-positive adolescents aged 10–19 years in such programs given the 
challenges faced by this subset of the population regarding adherence as well as transition from pediatric 
to adult care. This raises some important research questions:
1. What is the level of retention in HIV and AIDS programs among HIV-positive adolescents aged 10–19 
years in the country?
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2. Are HIV-positive adolescent clients who remain in HIV and AIDS programs different from those who 
drop out in terms of sociodemographic characteristics?
Understanding the extent to which adolescents aged 10–19 years who are living with HIV are retained 
in HIV care, treatment, and support is important for informing the design of effective comprehensive 
services for this subset of the population in order to better meet their needs across three main areas of 
HIV and AIDS programming: treatment; care and support; and prevention. Effective, comprehensive 
services that benefit adolescents and contribute towards their retention in HIV care, treatment, and 
support programs are a pressing priority for the national AIDS control programs in many countries 
affected by the epidemic. Retention in HIV programs is, in turn, important for positive clinical outcomes 
including viral suppression and survival (Giordano 2012; Giordano et al. 2007; WHO 2012). 
In 2013–2014, The AIDS Support Organization (TASO) and the Population Council undertook a 
study to generate evidence on the level of and the factors associated with retention of adolescents aged 
10–19 years in HIV and AIDS programs in Uganda. The study was conducted under the U.S. Agency 
for International Development’s (USAID) HIVCore project led by the Population Council. The study 
further responds to the guidelines by the World Health Organization (WHO) and the United Nations 
Fund for Population Activities (UNFPA) on care, treatment, and support for women living with HIV and 
AIDS and their children in resource-constrained settings that emphasize ensuring the availability of age-
appropriate information and counseling on SRH and safer sexual practices, and offering family planning 
counseling and services that are adolescent-friendly (WHO and UNFPA 2006).
The goal of the study was to generate evidence on the level of and the factors associated with retention of 
HIV-positive adolescents aged 10–19 years in HIV and AIDS programs in Uganda. The specific objectives 
of the study were to:
1. Examine the contextual factors that might facilitate or influence retention of adolescents in HIV care, 
treatment, and support services in Uganda.
2. Examine the cascade of HIV care, treatment, and support services among adolescents aged 10–19 years 
in Uganda and how these patterns compare with those of adults aged 20 years and above.
3. Examine the level of and trend in retention in care, treatment, and support programs among 
adolescents aged 10–19 years in the country in the context of current HIV and AIDS programs at 6, 
12, 24, 36, and 48 months following initiation of ART.
4. Assess the sociodemographic characteristics and clinical factors that are associated with retention in 
HIV care, treatment, and support programs among adolescents in Uganda at three different follow-up 
periods (12, 24, and 36 months).
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methoDoLogY
StuDY DeSign AnD SAmpLe
The study used existing national policy and program documents on HIV testing, counseling, treatment, 
and support as well as retrospective secondary cohort clinical data from 11 clinics operated by TASO in 
Uganda. The study population for the clinical component comprised:
1. 22,089 adolescents aged 10–19 years and 33,139 adults aged 20 years and above regardless of HIV 
status who received HIV services under the home-based HIV testing and counseling (HBHTC) 
program from 2005 (when TASO initiated the program) to 2011.
2. Clinical records of 617 HIV-positive adolescent clients aged 10–19 years (at the time of enrollment) 
who received HIV care, treatment, and support services from TASO clinics between 2006 and 2011.
The steps in sample selection for each of the study populations are summarized in Figure 1.
figure 1  flow chart showing steps in sample selection
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review of DoCumentS 
The review of policy and program documents as well as the extraction and merging of clinical datasets 
took place from 4–15 November 2013. The policy and program documents were obtained from TASO 
and Uganda’s Ministry of Health. We undertook a review of the existing HIV and AIDS treatment, care, 
and support program documents in Uganda (such as national policy guidelines on service provision 
and training manuals for service providers) to determine the contextual factors that might facilitate or 
influence enrollment into HIV care, initiation of treatment, and retention in treatment programs among 
adolescents living with HIV. The results of the review are presented in the appendix.
extrACtion of CLiniCAL DAtASetS
The HBHTC and ART datasets were obtained from 11 TASO centers. The HBHTC datasets included 
all individuals who were counseled and tested for HIV under the program regardless of whether they 
were later enrolled in TASO programs. The ART datasets, on the other hand, comprised all individuals 
who were enrolled in TASO programs regardless of where they were counseled and tested for HIV. 
The ART datasets were extracted from the following records: Pre-ART Registry, Case Evaluation, ART 
Commencement, Deaths, Monitoring Refills, and Laboratory (Figure 1). A cohort of adolescent clients 
aged 10–19 years who were initiated on ART between January 2006 and December 2011 at TASO 
clinics were included in the analysis. TASO collects information on date of testing, date of enrollment 
in care and support programs, date of confirmation of eligibility for antiretroviral drugs (ARVs), date of 
commencement of ARVs, and dates of drug refills since the client was started on ARVs. The ART datasets 
for the various components of HIV care, treatment, and support including registration, determination of 
eligibility for ART, and commencement and adherence to treatment from all the eleven centers are stored 
in separate files in Access format at TASO headquarters and include all age groups. However, each file 
contains unique client identifier numbers that were used to merge information pertaining to the same 
client from the different datasets.
DAtA AnALYSiS
Analysis involved both descriptive statistics and multivariate Cox regression analysis. Descriptive analysis 
entailed reviewing the cascade of HIV care, treatment, and support services under the HBHTC program 
as well as estimating the level of retention in TASO ART programs. The review of the cascade of care 
was conducted for adolescents aged 10–19 years and adults aged 20 years and above. Analysis entailed 
simple frequencies to determine the proportions of adolescents and adults that: (i) tested positive among 
those who received HBHTC since 2005; (ii) were enrolled in care and support programs at TASO centers 
among those who tested positive during HBHTC; (iii) were determined to be eligible for ART among 
those who were enrolled in care and support programs at TASO centers; and (iv) were started on ART 
among those who were determined to be eligible. The purpose of the analysis was to determine whether 
the proportions of adolescents were significantly different from those of adults at each stage in the cascade. 
Significance tests of proportions were conducted to determine whether the differences between the two 
groups were statistically significant.
With respect to the level of retention, the percentage of patients with HIV known to be on treatment 
6 and 12 months after initiation of ART and at yearly intervals thereafter (e.g., 24, 36, 48 months) is 
recommended as a core indicator for documenting program retention over time (Tassie et al. 2010). It is 
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generated per calendar year by selecting all patients starting ART during a given year (denominator) and 
reporting those who are still alive and on ART at a specific time point (numerator)—that is, excluding 
those who were known to have died, stopped ART, or were lost to follow-up (Tassie et al. 2010). We 
calculated retention rate as the proportion of patients who were enrolled in TASO centers and alive 
(including those who transferred to non-TASO centers) at the end of each observation period at 6, 12, 
24, 36, and 48 months. We further examined whether the level of retention at each observation period 
differed among adolescents initiating treatment in each successive year from 2006 to 2010, which could 
give an indication of the changing programmatic contexts. 
Multivariate analysis was conducted to determine the sociodemographic and clinical factors associated 
with program attrition at 12, 24, and 36 months.1 The analysis involved estimation of three separate 
Cox proportional hazard models for each of the time periods with exposure defined from the time of 
enrollment in the ART program to the end of analysis period (i.e., at 12, 24, and 36 months). The 
incidence rates of subcategories of attrition (dead, lost to follow-up [LTFU], and treatment stopped) were 
expressed as the number of patients with at least one occurrence of the given event per 100 person years. 
A two-tailed statistical test with a p-value of <0.05 was considered to be statistically significant. Baseline 
characteristics included patient’s sociodemographics such as age (10–14 and 15–19 years), sex (male 
and female), and religious affiliation (Anglican, Catholic, Muslim, and Protestant); available measures 
of disease severity including CD4 count (<100 cells/µl, 100–249 cells/µl, and 250 or more cells/µl) and 
WHO clinical staging (Stage 1&2 and Stage 3&4); adherence level (<75 percent, 75 percent–95 percent, 
and greater than 95 percent); and mode of ART delivery (community drug distribution points [CDDP] 
and health facility). Adherence level was determined by the frequency of taking drugs based on a three-
day recall and pharmacy records within a given quarter. Patients were defined as LTFU if their last patient 
contact was more than three months before the end date of the observation period and were considered 
to have been lost to follow up at their last contact date. The results are presented as adjusted hazard ratios 
(AHR) with 95 percent confidence intervals (CI).
ethiCAL ConSiDerAtionS
The study obtained ethical approval from the Population Council Institutional Review Board, TASO 
Institutional Review Committee and the Uganda National Council for Science and Technology 
(UNCST). In addition, no personal identifiers such as names, addresses, or contact information of clients 
were included in the extracted clinical data. Rather, a unique patient identification number was used to 
merge the datasets from the various records.
1At 48 months, the model could not converge because of missing data.
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KeY finDingS
ChArACteriStiCS of ADoLeSCentS
Table 1 presents the distribution of adolescents who were enrolled in TASO programs during the period. 
The majority of the adolescents were female (63 percent), reflecting the generally higher HIV prevalence 
among women (8 percent) than men (6 percent) in the country (Ministry of Health et al. 2012). 
More than half (55 percent) of the adolescents were aged 10–14 years while 75 percent had primary 
level education. Most of the adolescents (73 percent) had CD4 counts of 100 and above at the time of 
initiating ART, while 91 percent had adherence level above 95 percent. One-quarter (25 percent) of the 
adolescents were sexually active (had ever had sex) suggesting that the majority were born with HIV. Most 
of the adolescents (62 percent) obtained their drug refills from a health facility (Table 1).
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table 1  Distribution of adolescents aged 10–19 years in tASo Art programs by 
background characteristics at the time of enrollment, 2006–2011
Characteristics percent number of 
adolescents
Sex of client
Female 63.2 390
male 36.8 227
Age (years)
10–11 26.6 164
12–14 29.2 180
15–17 22.8 141
18–19 21.4 132
highest level of education completed
none/pre-primary   7.3   45
primary 75.0 461
Senior 1–4 15.9   98
Senior 5 and above   1.8   11
religion
Anglican 36.0 221
Catholic 42.4 260
muslim 10.6   65
pentecostal   7.8   48
Seventh Day Adventist   1.1     7
Other   2.1   13
Venue of ARV refill
CDDp 36.3 224
health facility 62.1 383
home/other   1.6   10
CD4 at Art initiation
<100 cells/µl 27.0 154
100–249 cells/µl 37.0 211
250 or more cells/µl 36.0 205
who clinical staging
Stage 1 & 2 71.5 436
Stage 3 & 4 28.5 174
Sexually active (ever had sex)
yes 24.6 143
no 75.4 139
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CASCADe of CAre unDer hbhtC progrAm
Between 2005 and 2011, TASO tested a total of 77,881 clients through the HBHTC program. Out of 
these, 28 percent were adolescents aged 10–19 years and 43 percent were adults aged 20 years and above. 
Table 2 presents the numbers of adolescents and adults that went through the cascade of the TASO 
HBHTC program during the period. 
table 2  number of adolescents 10–19 years and adults 20 years and above who 
received various hiv services through the tASo hbhtC program, 2005–2011
Year
number 
tested
number 
positive
number 
enrolled
number 
eligible for 
Art
number 
initiated 
on Art
Adolescents 10–19 years
2005          675            33               3               1               1 
2006       4,447          126             40               6               5 
2007       3,833            73             29               7               5 
2008       2,966            64             26               9               9 
2009       4,318            68             21               6               6 
2010       5,076            79             16               6               5 
2011          774            18               5               2               2 
Total     22,089           461           140             37             33 
Adults 20 years and above
2005          732          104             22               6               6 
2006       5,214          557           179             29             28 
2007       5,336          656           213             76             72 
2008       3,782          529           161             57             52 
2009       7,570          794           127             38             34 
2010       9,079          920           203              61             57 
2011       1,426          178             29             10               8 
Total     33,139        3,738           934           277           257 
Overall, 8 percent of adolescents and adults tested through the program were HIV-positive (2 percent 
of adolescents and 11 percent of adults; Figure 2). As expected the proportion of adolescents who tested 
positive was consistently lower than that of adults across the years (p<0.01 in all cases). Over time, the 
proportion of adolescents that tested positive under the program declined by more than half from 5 
percent in 2005 to 2 percent in 2011. However, the proportion of adults aged 20 years and above that 
tested positive under the program fluctuated between 10 percent and 14 percent (Figure 2). 
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figure 2  percentage of adolescents 10–19 years and adults 20 years and above who 
were hiv-positive among those tested through the tASo hbhtC program, 2005–2011
Under the HBHTC program, the proportion of HIV-positive adolescents that were enrolled in TASO 
centers more than tripled from 9 percent in 2005 to 32 percent in 2006 and steadily increased to 40 
percent and 41 percent in 2007 and 2008 respectively (Figure 3). Nonetheless, the proportion of HIV-
positive adolescents that were enrolled in TASO programs declined to 31 percent and 20 percent in 2009 
and 2010 respectively. By contrast, the proportion of HIV-positive adults that were enrolled in TASO 
centers increased by 11 percentage points between 2005 and 2006 (from 21 percent to 32 percent) before 
levelling off at 33 percent in 2007. In addition, the proportion of adults that were enrolled in TASO 
programs declined to 30 percent and 16 percent in 2008 and 2009 respectively (Figure 3). It is also 
worth noting that during the first year of the program, a higher proportion of HIV-positive adults than 
adolescents were enrolled in TASO centers. However, in 2006, a similar proportion of HIV-positive adults 
and adolescents were enrolled in TASO programs while between 2007 and 2009, a higher proportion of 
HIV-positive adolescents compared to adults were enrolled in the centers.
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figure 3  percentage of adolescents 10–19 years and adults 20 years and above who 
were enrolled in tASo centers among those who tested positive through the hbhtC 
program, 2005–2011
Figure 4 presents the distribution of adolescents 10–19 years and adults aged 20 years and above who 
were eligible for ART among those who were enrolled in TASO programs between 2005 and 2011. With 
the exception of a slight decline in 2009, the proportion of adolescents who were found to be eligible 
for ART more than doubled from 15 percent in 2006 to 40 percent in 2011. Over the same period, the 
proportion of adults aged 20 years who were found to be eligible for ART more than doubled between 
2006 and 2007 (from 16 percent to 36 percent) but fluctuated between 30 percent and 35 percent 
thereafter  (Figure 4). Among those who were eligible for treatment between 2005 and 2011, 89 percent 
of adolescents and 93 percent of adults were initiated on TASO ART programs.
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figure 4  percentage of adolescents 10–19 years and adults 20 years and above who 
were eligible for Art among those enrolled in tASo centers through the hbhtC 
program, 2005–2011
LeveL of retention of ADoLeSCentS in Art progrAmS
Out of the 617 HIV-positive adolescents included in the study, 78 percent were still in TASO programs 
and 6 percent had died, while 15 percent were lost to follow up during the review period. As expected, 
the level of retention of adolescents declined with longer duration of stay in TASO ART programs. The 
overall level of retention of adolescents in the programs was 96 percent at 6 months, 90 percent at 12 
months, 83 percent at 24 months, 76 percent at 36 months, and 71 percent at 48 months (Figure 5). 
figure 5  overall level of retention of adolescents 10–19 years in tASo Art programs, 
2006–2011
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trenDS in retention of ADoLeSCentS in Art progrAmS
Figure 6 presents the level of retention of various cohorts of adolescents in TASO ART programs. There is 
little variation in the level of retention between different cohorts at 6 months (ranges from 93 percent for 
the 2010 cohort to 100 percent for the 2006 cohort). At 12 months, however, there were wide variations 
in the level of retention especially between the 2010 cohort and the other cohorts (79 percent for the 
2010 cohort and over 90 percent for the 2006, 2007, 2008, and 2009 cohorts). The gaps in the level 
of retention between cohorts of adolescents further widen as the duration increases to 24, 36, and 48 
months, with the level of retention of later cohorts of adolescents being lower than that of earlier cohorts 
(Figure 6). 
figure 6  trends in retention of various cohorts of adolescents 10–19 years in tASo Art 
programs, 2006–2011
fACtorS ASSoCiAteD with non-retention of 
ADoLeSCentS in Art progrAmS
The results of the multivariate analysis predicting non-retention of adolescents aged 10–19 years in 
TASO ART programs at various time points are presented in Table 3. The risk of non-retention in ART 
programs was significantly greater among adolescents who obtained their ARV refills from a health facility 
than among those who obtained the refills from CDDP at all the time points considered (i.e., 12, 24, and 
36 months). In particular, the risk of non-retention was greater by 2.58 times at 12 months (95% CI: 
1.26, 5.29), 1.59 times at 24 months (95% CI: 1.23, 2.05), and 1.31 times at 36 months (95% CI: 1.05, 
1.61; Table 2) among adolescents who obtained their ARV refills from a health facility compared to those 
who obtained the refills from CDDP. It is also worth noting that the magnitude of the differences in the 
risk of non-retention in care by mode of ARV delivery reduced with time.
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The results in Table 3 further show that at 24 and 36 months, the risk of non-retention in care was 
significantly greater (by between 1.33 and 1.41 times) among adolescents with higher compared to those 
with lower CD4 count at the time of ART initiation. There was, however, no significant difference in 
the risk of non-retention in care by the level of CD4 count at 12 months (Table 3). By contrast, there 
was significant difference in the risk of non-retention in care by WHO clinical staging at 12 months but 
not at 24 and 36 months. At 12 months, the risk of non-retention in care was 2.21 times greater among 
adolescents at stage 3 and 4 than among those at stage 1 and 2 at the time of initiating ART. 
With respect to age, the risk of non-retention in care was significantly greater among older (15–19 years) 
than among younger (10–14 years) adolescents during the first two years following ART initiation. The 
risk of non-retention was 1.88 times greater at 12 months (95% CI: 1.01, 3.48) and 1.30 times greater 
at 24 months (95% CI: 1.02, 1.66) among older compared to younger adolescents. However, by the 
third year, there was no significant difference in the risk of non-retention between older and younger 
adolescents. The results also show that with longer duration of observation, the risk of non-retention in 
care was significantly lower among male than among female adolescents. The risk was lower by 0.68 times 
at 24 months (95% CI: 0.52, 0.88) and by 0.79 times at 36 months (95% CI: 0.64, 0.98) among male 
compared to female adolescents. There was, however, no significant difference in the risk of non-retention 
in care by sex of the adolescent at 12 months.
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table 3  hazard ratios from multivariate analysis predicting non-retention of 
adolescents aged 10–19 years in tASo Art programs at various time points, 2006–2011
Covariate 12 months 
Ahr (95% Ci)
24 months 
Ahr (95% Ci)
36 months 
Ahr (95% Ci)
Sex of client (ref: male)
Female 1.09
(0.59, 2.02)
   0.68**
(0.52, 0.88)
 0.79*
(0.64, 0.98)
Age of client (ref: 10–14 years)
15–19 years  1.88*
(1.01, 3.48)
 1.30*
(1.02, 1.66)
1.21
(0.98, 1.49)
religion (ref: Anglican)
Catholic 1.05
(0.53, 2.10)
1.15
(0.88, 1.52)
1.16
(0.92, 1.46)
muslim 0.63
(0.18, 2.20)
0.88
(0.55, 1.38)
0.92
(0.62, 1.33)
protestant 1.65
(0.69, 3.92)
1.14
(0.77, 1.70)
1.19
(0.85, 1.67)
mode of Arv delivery (ref: CDDp)
health facility    2.58**
1.26, 5.29)
   1.59**
(1.23, 2.05)
  1.31*
(1.05, 1.61)
who clinical staging at Art 
initiation (ref: Stage 1 & 2)
Stage 3 & 4   2.21*
(1.19, 4.09)
0.99
(0.75, 1.31)
0.94
(0.74, 1.18)
CD4 at Art initiation  
(ref: <100 cells/µl)
100–249 cells/µl 1.13
(0.58, 2.20)
 1.38*
(1.01, 1.90)
 1.36*
(1.05, 1.77)
≥250 cells/µl 0.48 
(0.20, 1.13)
  1.41*
(1.02, 1.96)
 1.33*
(1.02, 1.75)
Adherence level (ref: <75%; poor)
75%–95% (Fair) 0.31
(0.05, 2.05)
2.09
(0.48, 9.03)
1.32
(0.46, 3.83)
>95% (good) 0.38
(0.08, 1.68)
1.84
(0.45, 7.55)
1.20
(0.44, 3.27)
person-years of observation 1,311.5863 1,311.5863 1,311.5863
number of persons 528 528 528
notes: Adherence level was determined by the frequency of taking drugs based on a three-day recall and pharmacy records 
within a given quarter; ref: reference category; *p<0.05; **p<0.01.
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ConCLuSionS AnD 
reCommenDAtionS
DiSCuSSion
The key findings of the study are that: 1) the overall level of retention of adolescents in TASO programs 
is comparable with those of adults in existing studies, although there were variations in the retention 
of various cohorts of adolescents especially from 12 months onwards; 2) the risk of non-retention of 
adolescents in TASO care programs was significantly greater among those who obtained their ARV refills 
from a health facility than among those who obtained the refills from community drug distribution points 
at all the time points considered (12, 24 and 36 months); the risk of non-retention was significantly 
greater among adolescents at WHO clinical stage 3 and 4 than among those at stage 1 and 2 at the time 
of initiating ART (at 12 months); 3) the risk of non-retention in TASO care was significantly greater 
among older (15–19 years) than among younger (10–14 years) adolescents (at 12 and 24 months) as well 
as among adolescents with higher than among those with lower CD4 count at the time of initiating ART 
(at 24 and 36 months); 4) the risk of non-retention in care was significantly lower among male compared 
to female adolescents with longer duration of observation (at 24 and 36 months); and 5) the proportion 
of HIV-positive adolescents that were tested under the HBHTC program and who were enrolled in 
TASO centers more than quadrupled between 2005 and 2008 before declining by about half between 
2008 and 2010.
The HIV and AIDS policy environment in Uganda is favorable for implementing interventions including 
testing, counseling, treatment, and support programs for various population groups. However, effective 
implementation of programs has been hampered by inadequate and inconsistent messaging, limited 
human and financial resources to meet the demand for services, and lack of efficient management of 
funds and supplies, as well as weak linkage and referral systems (Ministry of Health 2011; Uganda AIDS 
Commission, n.d.). In addition, HIV-positive adolescents aged 10–19 years face challenges associated 
with adherence to treatment and program retention as they transition from pediatric to adult care (Foster 
and Fidler 2010). There are, however, no clear policy or programmatic actions aimed at reducing the 
potential drop-out from care among adolescents during the transition from pediatric to adult care that is 
evident from the review of policy and program documents. There is therefore need for clear policies and 
concrete programs that address retention of HIV-positive adolescents in ART programs as they transition 
from pediatric to adult care in the country.
Long-term retention of clients in ART programs is considered a major challenge for HIV programs 
in sub-Saharan Africa (Harries et al. 2010). Studies show that although retention of clients in ART 
programs in the region is more than 90 percent at 6 months, it declines with time ranging between 80 
and 90 percent at 12 months, 70 and 80 percent at 24 months, and 60 and 70 percent at 36 months 
(Geng et al. 2011; Fox and Rosen 2010; Tayler-Smith et al. 2010). In Uganda, it was estimated that as of 
2011, 84 percent of clients were still on ART after 12 months of initiation (Republic of Uganda 2012). 
Although the programmatic challenges are likely to affect the level of retention of adolescents in ART 
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programs, the findings of this study show that the overall retention of adolescents in TASO programs is 
comparable with those of adults in existing studies (Geng et al. 2011; Fox and Rosen 2010; Ministry of 
Health 2011; Republic of Uganda 2012; Tayler-Smith et al. 2010). However, there were variations in 
the level of retention of various cohorts of adolescents especially from 12 months onwards. Specifically, 
retention decreased at each time period among adolescents initiating ART in each successive year since 
2006 and the gaps widened with longer duration of observation. Whereas this could be an indication 
of the changing program context (such as availability of funding, expansion of clinics leading to clients 
transferring from TASO to new clinics, and changing treatment guidelines over the period), the design 
of the study did not allow for exploring the specific reasons for the variations in the levels of retention of 
adolescents by the year of initiating ART. It is, however, worth noting that the high levels of retention of 
adolescents in TASO treatment programs could be due to the intensive resources geared toward targeting 
whole families with HIV testing, counseling, treatment, and support services. Thus, although resources 
for targeting whole families may not always be available, the programs provide valuable lessons for 
improving access to treatment services among HIV-positive adolescents. 
The second important finding of this study is that the risk of non-retention of adolescents in TASO care 
programs was significantly greater among those who obtained their ARV refills from a health facility than 
among those who obtained the refills from community drug distribution points at all the time points 
considered (12, 24, and 36 months). In addition, at 12 months, the risk of non-retention in care was 
significantly greater among adolescents at WHO clinical stage 3 and 4 than among those at stage 1 and 
2 at the time of initiating ART. The findings suggest that community-based ART distribution initiatives 
and early diagnosis of HIV infection do improve the chances of retaining adolescents in ART programs. 
Community-based initiatives have been found to increase the uptake of HIV services in sub-Saharan 
Africa (Matovu and Makumbi 2007). Early initiation of ART has, on the other hand, been associated 
with decreasing trends in AIDS-related mortality in the country (Ministry of Health 2011). Variations 
in the risk of non-retention in the TASO treatment programs by venue of drug refills could be due to the 
fact that most HIV-positive adolescents with high levels of adherence receive drugs from community drug 
distribution points while the less adherent ones receive drugs from health facilities. Nonetheless, a cross-
tabulation of adherence level and venue of drug refill showed that there was no significant association 
between the two attributes, suggesting that counseling and close monitoring might have improved 
adherence among clients who received drug refills from facilities.
The third key finding of the study is that the risk of non-retention in TASO care was significantly 
greater among older (15–19 years) than among younger (10–14 years) adolescents at 12 and 24 months. 
In addition, at 24 and 36 months, the risk of non-retention in care was significantly greater among 
adolescents with higher than among those with lower CD4 count at the time of initiating ART. The 
higher risk of non-retention among older compared to younger adolescents could be due to challenges 
associated with transitioning from pediatric to adult care, given that ages 15–19 years also mark transition 
to adulthood. Differences in retention by CD4 count could be due to the fact that adolescents with 
higher CD4 count at the time of initiating ART may presume that they are healthy and might therefore 
not feel the need to continue with treatment. 
Available evidence indicates that women have better health-seeking behavior than men and that those 
who are living with HIV are likely to initiate treatment earlier than men (Braitstein et al. 2008). Contrary 
to this expectation, the results of the study show that the risk of non-retention in care was significantly 
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lower among male compared to female adolescents with longer duration of observation (at 24 and 36 
months). However, given that the study was based on secondary data, it was not possible to explore 
further the reasons for lower risk of non-retention in care among male compared to female adolescents.
With respect to HBHTC, the program contributed to increasing proportions of adolescents aged 10–19 
years being enrolled in TASO care centers during the first four years of its operation. In particular, the 
proportion of HIV-positive adolescents who were enrolled in TASO centers more than quadrupled 
between 2005 and 2008. However, the proportion of adolescents enrolled in TASO care centers under 
the program declined by about half between 2008 and 2010. The initial success of the program and 
the subsequent decline in the proportions of adolescents being in enrolled in care could partly reflect 
the interplay between a supportive policy environment and the challenges associated with program 
implementation in the country including the availability of adequate resources (Ministry of Health 2011; 
Uganda AIDS Commission, n.d.). The overall proportions of adolescents who were tested through the 
program and enrolled in TASO care centers also remained low across the years. This could largely be 
due to the fact that although clients accepted being counseled and tested at home by TASO, it was not a 
pre-condition that they had to enroll in TASO care centers. Rather, they might have chosen to enroll for 
services elsewhere, which was entirely within their rights. 
ConCLuSion
Although the level of retention of adolescents aged 10–19 years in TASO care centers is comparable to 
those of existing studies among adults, significant variations exist at various time points by cohort, age, 
sex, mode of ART delivery, WHO clinical staging, and CD4 count at the time of initiating treatment. 
However, the findings show that community drug distribution points do improve retention of adolescents 
in HIV care and treatment programs. Nonetheless, given the potential for selection bias, more research 
is needed to determine whether the approach should be used to specifically target those at high risk of 
dropping out of care and treatment programs. 
reCommenDAtionS
 y HIV care, treatment, and support programs in Uganda should strengthen such strategies as community 
drug distribution points, which have the potential of improving retention of adolescents in care and 
treatment, to specifically target those who are at high risk of dropping out.
 y Since the issue of retaining older adolescents in HIV care and treatment programs could partly be 
associated with challenges with transition from pediatric to adult care, more research is needed to 
determine whether setting up transition units to cater for those who receive services from health 
facilities but are not comfortable with obtaining services from pediatric or adult clinics could improve 
retention. 
 y Further research involving collection of primary quantitative and qualitative data is needed to 
determine why later cohorts of adolescents had lower levels of retention in care compared to earlier 
cohorts and why male adolescents had significantly lower risk of non-retention in care compared to 
their female counterparts. 
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AppenDix:  
DoCument review
poLiCY Context
infrastructure
The first AIDS case was diagnosed in Uganda in 1982 and by 1986, the disease had reached the level 
of a generalized epidemic predominantly transmitted through heterosexual contact (Ministry of Health 
and ORC Macro 2006; Serwadda et al. 1985). In response, the Ugandan government (the Government) 
established the AIDS Control Programme in the Ministry of Health in 1986 to carry out epidemiological 
surveillance of the epidemic; ensure safe supply of blood for transfusion; and provide information, 
education, and communication (IEC) as well as patient care and counseling services (Uganda AIDS 
Commission 2000). The Government adopted a multi-sectoral approach in dealing with the epidemic 
in 1990/1991. The Uganda AIDS Commission was created in 1992 to coordinate the multi-sectoral 
response encompassing HIV prevention, counseling, testing, care, and support services involving public, 
private, civil society, and community-based organizations (Ministry of Health and ORC Macro 2006). 
hiv prevention policy
In 1999, the Government issued the National Health Policy with one of its priorities being the prevention 
and control of HIV. This was to be achieved through information, education, and communication (IEC) 
campaigns; HIV counseling and testing; promotion of condom use; treatment of sexually transmitted 
infections (STIs); reduction of mother-to-child transmission; provision of palliative care; and promotion 
of community involvement in the care of patients with AIDS (Ministry of Health 1999). In 2000, 
the Government unveiled the National Strategic Framework for AIDS Activities in the country for the 
period 2001–2006 focusing on promotion of abstinence, faithfulness, and condom use (ABC); reducing 
mother-to-child transmission of HIV as well as providing care and support to households affected by the 
epidemic (Uganda AIDS Commission 2000). At the expiration of the National Strategic Framework, the 
Government developed a new strategic plan in 2007, the National HIV&AIDS Strategic Plan 2007–2012, 
which had goals to reduce the incidence of HIV and AIDS by 40 percent and to expand care, treatment, 
and support interventions to 80 percent of those in need by the year 2012 (Uganda AIDS Commission 
2007). In addition, the policies and strategic plans recognized the importance of addressing underlying 
factors that constrain HIV prevention such as harmful sociocultural and gender norms, inequitable access 
to services, gender-based violence, and stigma and discrimination (Ministry of Health 1999; Uganda 
AIDS Commission 2000, 2007).
hiv testing and counseling policy
The Government issued the first Voluntary Counseling and Testing (VCT) Policy in 2002, which had the 
goal of ensuring access to high-quality VCT services for all people in Uganda (Ministry of Health 2010a, 
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2010b). The policy was revised in 2005 to HIV Counselling and Testing Policy in order to encompass new 
models of testing including provider-initiated testing and counseling (PITC) and HBHTC (Ministry 
of Health 2005, 2010a, 2010b). The policy was again revised in 2010 to take into account emerging 
issues such as key populations, special groups including children and persons with disabilities, quality 
assurance, safe medical circumcision, and ethical and legal issues around HIV counseling and testing 
(Ministry of Health 2010a). The Government further issued the National Implementation Guidelines for 
HIV Counselling and Testing in the country at the same time to guide the implementation of the HIV 
Counselling and Testing Policy (Ministry of Health 2010b). 
hiv treatment, care and support policy
With respect to treatment, care and support services, the Government developed the Antiretroviral 
Treatment Policy for Uganda in 2003, with objectives to: (1) standardize the provision of ART and related 
services to adults and children; (2) build capacity of healthcare workers to provide ART in a safe, effective, 
and integrated manner; and (3) ensure uninterrupted supply of antiretroviral (ARV) drugs, laboratory 
reagents, and medical supplies (Ministry of Health 2003a). The Government further issued the Policy for 
Reduction of the Mother-to-Child HIV Transmission in Uganda in the same year. The objective of this policy 
was to guide the provision of ART for prevention of mother-to-child transmission (PMTCT) of HIV 
and reduce pediatric HIV cases (Ministry of Health 2003b). In 2009, the Government unveiled revised 
ART guidelines for adults, adolescents, and children to take into account the 2006 revision of WHO 
global ART recommendations (Ministry of Health 2009a; WHO 2006). Improving access to quality HIV 
treatment and care services was also a key focus of the third Health Sector Strategic Plan for the period 
2010–2015 and the National Strategic Plan for HIV&AIDS for the period 2011–2015 (Ministry of Health 
2010c; Republic of Uganda 2011). 
One of the Government’s policy goals is to mitigate the health and socio-economic effects of HIV and 
AIDS on individuals, households, and communities in Uganda (Uganda AIDS Commission 2000). 
Besides treatment, nutritional support is one strategy that the Government has outlined for mitigating 
the health impact of the epidemic. To this end, the Government issued guidelines for service providers 
on nutritional care and support for people living with HIV in the country (Republic of Uganda, n.d.). 
In addition, the Health Sector Strategic Plan III for the period 2010–2015 emphasized incorporating 
nutritional support into the management and treatment of HIV and AIDS (Ministry of Health 2010c). 
Other care and support strategies that the Government has outlined in various policy documents include: 
(1) promoting palliative care and social and spiritual support for children infected and affected by HIV 
and AIDS; (2) providing psychosocial, financial, and material support (shelter, food, school fees) to AIDS 
orphans, child-headed households, and guardians/foster families; (3) promoting home-based care for 
people living with HIV; (4) developing income-generating projects with skills development components 
and training family members in the management and monitoring of the projects; and (5) identifying 
non-governmental organizations (NGOs) and micro-financing institutions to extend credit to the families 
most affected by HIV and AIDS (Uganda AIDS Commission 2000, 2007; Ministry of Health 2003).
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progrAmmAtiC Context
ieC/bCC campaigns
The first AIDS control program was set up in Uganda in 1987 with an emphasis on the ABC approach 
to HIV prevention (Genuis and Genuis 2005; Green et al. 2006; Ministry of Health and ORC Macro 
2006). The approach involved IEC/behavior change communication (BCC) campaigns using various 
channels including mass media (print materials, radio, and billboards), community mobilization, and 
interpersonal communications (Green et al. 2006). The campaigns targeted the general population as 
well as specific groups such as youth, female sex workers and their clients, traders, fishermen, soldiers, 
long distance drivers, bar girls, police, and students (Green et al. 2006). The messages focused not only 
on ABC but also cross-generational sex as well as modes of HIV transmission (Green et al. 2006). The 
campaigns have been carried out throughout the country by the Government as well as faith-based, civil 
society, and community-based organizations (Green et al. 2006; Okware et al. 2005). 
hiv counseling and testing services
The ABC prevention strategy was later expanded to include HIV counseling and testing (HCT), PMTCT, 
ART, and HIV care and support services—a strategy also known as ABC Plus (Ministry of Health and 
ORC Macro 2006). The country employs various HCT models including routine HIV counseling 
and testing for pregnant women (sentinel surveillance), VCT or client-initiated counseling and 
testing (CICT), PITC, HBHTC, couples HIV counseling and testing (CHCT), mobile HIV testing, 
and moonlight (night-time) testing for high-risk groups such as sex workers (Ministry of Health 2005; 
Republic of Uganda 2011). The sentinel surveillance system was established in 1985 in Kampala before 
being rolled out to other sites in 1989 (Garbus and Marseille 2003). Between 1989 and end of 2001, 
the number of sentinel sites increased from six located in a few places in and outside Kampala to 20 sites 
spread throughout the country but mostly in urban and peri-urban clinics (Garbus and Marseille 2003). 
VCT was first launched in the country in 1990 with the establishment of the AIDS Information Center 
(AIC) in Kampala and by 2002, AIC had 70 sites in 34 districts (Garbus and Marseille 2003; Menzies 
et al. 2009; Ministry of Health 2010a). The Ministry of Health started a voluntary door-to-door HIV 
counseling and testing program in 1999 (Menzies et al. 2009; Wanyeze et al. 2008). The Ministry further 
launched the national couples HIV counseling and testing in the same year under the campaign ‘Go 
Together, Know Together’ (Ministry of Health 2009b). In addition, the Government began rolling out 
PITC in 2013 after initial piloting of the strategy in regional referral hospitals (Kajja 2013). Moonlight 
HIV counseling and testing was, on the other hand, first piloted by AIC in Arua district in 2007 before 
being rolled out to other districts (AIC 2013). Thus, HCT services have been expanded in all districts in 
the country with the national guidelines allowing for provision of the services in health facilities (public, 
private, faith-based, and NGO), community settings (e.g., stand-alone sites, home or workplace), and in 
special circumstances such as surveillance or research settings (Ministry of Health 2010b). By 2011, HCT 
services were available in all hospitals and Health Center Level IV, 80 percent of Health Center Level III, 
and 22 percent of Health Center Level II facilities (Republic of Uganda 2012). Estimates from the 2011 
Uganda AIDS Indicator Survey show that 60 percent of adults aged 15–49 years had ever been tested for 
HIV (Ministry of Health et al. 2012).
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treatment services
The Ministry of Health began offering free PMTCT services in 2000 (WHO et al. 2009). However, by 
2005, the proportion of HIV-positive mothers receiving PMTCT services was only 12 percent (WHO 
et al. 2009). By 2010, 1,150 health facilities were providing PMTCT services in the country including 
all public and private hospitals and Health Center Level IV, 90 percent of Health Center Level III, and 
10 percent Health Center Level II facilities (Republic of Uganda 2012). Over the same period, the 
proportion of HIV-positive mothers receiving PMTCT services in the country increased to 53 percent 
(WHO et al. 2010). Since the Government launched universal access to free antiretroviral drugs in 2004, 
a total of 409 public and private facilities had been accredited to provide ART by the end of December 
2008, and, of the 357,000 people estimated to need treatment, about 168,000 were already accessing 
ART countrywide (Ministry of Health 2009). By 2011, it was estimated that 58 percent of adults and 
children in need of ART were accessing the services (Republic of Uganda 2012). 
Care and support services
With respect to care and support, efforts by the government, private sector, and civil society organizations 
(CSOs) have focused on alleviating the impact of HIV and AIDS on people living with HIV, orphans 
and vulnerable children (OVC), and affected households and communities (Republic of Uganda 2012). A 
2009 evaluation of forms of care available at sampled health facilities in the country found that the most 
common components were adherence counseling, nutritional advice, family planning counseling, pre- 
and post-HIV test counseling, treatment for diarrhea, and treatment for skin rash (Harding et al. 2009). 
Other forms of care and support include psychosocial support services especially for OVC, including life 
skills, counseling and guidance, formal education, and vocational training (Harding et al. 2009; Republic 
of Uganda 2012). The universal primary and secondary education initiatives by the government have, 
for instance, led to continued increase in the number of OVC in primary and secondary schools in the 
country (Republic of Uganda 2012). In addition, some CSOs have interventions addressing household 
food insecurity and malnutrition while the government’s Social Assistance Grants for Empowerment 
(SAGE) program initiated in 2010 aims to provide social protection to poor households (Republic of 
Uganda 2012).
SummArY AnD impLiCAtionS
In summary, the HIV and AIDS policy environment in Uganda is favorable for implementing 
interventions including testing, counseling, treatment, and support programs for various population 
groups. The policies have also been consistently updated in line with national and international 
developments regarding the epidemic. For instance, the revised National Strategic Plan for HIV&AIDS 
for the period 2011–2015 took into account the principles of combination prevention, which has been 
defined as “rights-based, evidence-informed, and community-owned programmes that use a mix of 
biomedical, behavioral, and structural interventions, prioritized to meet the current HIV prevention 
needs of particular individuals and communities, so as to have the greatest sustained impact on reducing 
new infections” (Republic of Uganda 2011; UNAIDS 2010b:8). In particular, the policies promote 
evidence-based interventions such as HIV counseling and testing, PMTCT, safe medical circumcision, 
ART, and condom use as well as behavioral and structural interventions including IEC/BCC, STI 
treatment, and medical infection control (Republic of Uganda 2011). The policies further outline 
measures for comprehensive social support protection for individuals, households, and communities to 
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enable them to prevent, manage, and overcome risks and vulnerabilities associated with the epidemic. It 
is, however, worth noting that some policies, such as the Anti-Homosexuality Act of 2014 (Ministry of 
Justice 2014), remain unfavorable for programs that target key populations such as men who have sex 
with men (Semugoma et al. 2012). There is also no clear policy that addresses retention of HIV-positive 
adolescents on ART as they transition from pediatric to adult care. 
In spite of the remarkable progress in HIV and AIDS programming in the country, challenges remain. 
For example, there have been inconsistencies in the IEC messages about the effectiveness of the various 
elements of the ABC strategy (A, B, and C) in changing behavior (Uganda AIDS Commission, n.d.). 
In addition, the IEC/BCC messages have largely been based on mass media campaigns rather than 
interpersonal communication (Uganda AIDS Commission, n.d.). There also has been limited emphasis 
on prevention counseling for individuals who test HIV-negative in order to remain uninfected (Uganda 
AIDS Commission, n.d.). Effective provision of HCT, PMTCT, and ART services is, on the other hand, 
hampered by limited human and financial resources to meet the demand, lack of efficient management 
of funds and supplies, and weak linkage and referral systems (Onyango and Magoni 2002; Republic 
of Uganda 2012). Budget constraints have also limited the country’s ability to address the needs and 
demands of people living with HIV, orphans, and affected households and communities (Republic of 
Uganda 2012). HIV-positive adolescents also face challenges associated with adherence to treatment 
and program retention as they transition from pediatric to adult care (Foster and Fidler 2010). These 
challenges may negatively impact the level of retention of adolescents in care, treatment and support 
programs in the country.
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